ShareValue scores for URT.WAR: Valuation 43, Quality 38, Growth 53, Health 43.
URT.WARGPW
Urteste SA
PLN 43.60
(-2.02%)
URT.WARGPW
Urteste SA
PLN 43.60(-2.02%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 16%
Rating
Trap Risk
Return
5% to 16%
Valuation
43
Fair Value
Price vs Value
Quality
38
Weak
Business Strength
Growth
53
Moderate
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
66
Bullish
Price Trend
Company Details
About
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.
Market Cap$67M
P/E RatioN/A
Dividend YieldNone
Sector Rank#2073
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026